Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | BCHE | P06276 | 1/20 | 0.47 |
| ▸ | TRPC3 | Q13507 | 1/20 | 0.47 |
| ▸ | TRPC4 | Q9UBN4 | 1/20 | 0.47 |
| ▸ | TRPC5 | Q9UL62 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.44 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.44 |
| ▸ | DRD2 | P14416 | 1/20 | 0.44 |
| ▸ | DRD3 | P35462 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzimidazole SCHEMBL10792070 | 0.92 | ALDH1A1 (0.41) | ALDH1A1NPC1RAB9ABCHETRPC3 | |
| SCHEMBL3706435 | 0.88 | ALDH1A1 (0.49) | ALDH1A1NPC1RAB9ABCHETRPC3 | |
| SCHEMBL3670861 | 0.85 | POLB (0.45) | ALDH1A1SMN1; SMN2LMNACYP2D6CYP2C19 | |
| Dimethirimol SCHEMBL11794538 | 0.85 | ALDH1A1 (0.38) | ALDH1A1NPC1RAB9ABCHETRPC3 | |
| SCHEMBL11305337 | 0.82 | SMN1; SMN2 (0.45) | ALDH1A1NPC1RAB9ASMN1; SMN2LMNA | |
| SCHEMBL3715154 | 0.79 | ALDH1A1 (0.47) | ALDH1A1NPC1RAB9ABCHETRPC3 | |
| SCHEMBL11198128 | 0.78 | POLB (0.46) | ALDH1A1NPC1RAB9ABCHETRPC3 | |
| SCHEMBL9241589 | 0.76 | ALDH1A1 (0.49) | ALDH1A1NPC1RAB9ABCHETRPC3 | |
| SCHEMBL4888617 | 0.75 | LMNA (0.56) | ALDH1A1NPC1RAB9ABCHESMN1; SMN2 | |
| SCHEMBL10576084 | 0.75 | ALDH1A1 (0.47) | ALDH1A1NPC1RAB9ABCHETRPC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030149088-A1 | HIV treatment | UNIVERSITY OF ARIZONA FOUNDATION (US) | 2003-08-07 | — | — | US | claimed |
| WO-2002041891-A2 | HIV TREATMENT WITH BENZIMIDAZOLES | THE PROCTER & GAMBLE COMPANY (US) | 2002-05-30 | — | — | WO | claimed |
| EP-0817564-B1 | MEDIUM FOR STORING, TRANSPORTING AND/OR GROWING A PLANT | RANPAK CORP (US) | 2000-10-11 | — | — | EP | claimed |
| US-5767138-A | ADMINISTERING TO MAMMAL 2-CARBAMYL-BENZIMIDAZOLE DERIVATIVE FUNGICIDE WITH SIDE EFFECT REDUCTION | PROCTER & GAMBLE COMPANY (US) | 1998-06-16 | — | — | US | claimed |
| EP-0831816-A1 | USE OF BENZIMIDAZOLES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF LEUKEMIA | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-01 | — | — | EP | claimed |
| EP-0821586-A1 | A PHARMACEUTICAL COMPOSITION CONTAINING BENZIMIDAZOLE FOR INHIBITING THE GROWTH OF CANCERS | THE PROCTER & GAMBLE COMPANY (US) | 1998-02-04 | — | — | EP | claimed |
| EP-0817564-A1 | MEDIUM FOR STORING, TRANSPORTING AND/OR GROWING A PLANT | RANPAK CORPORATION (US) | 1998-01-14 | — | — | EP | claimed |
| WO-1996040122-A1 | USE OF BENZIMIDAZOLES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF LEUKEMIA | THE PROCTER & GAMBLE COMPANY (US) | 1996-12-19 | — | — | WO | claimed |
| WO-1996032107-A1 | A PHARMACEUTICAL COMPOSITION CONTAINING BENZIMIDAZOLE FOR INHIBITING THE GROWTH OF CANCERS | THE PROCTER & GAMBLE COMPANY (US) | 1996-10-17 | — | — | WO | claimed |
| WO-1996028013-A1 | MEDIUM FOR STORING, TRANSPORTING AND/OR GROWING A PLANT | RANPAK CORP. (US) | 1996-09-19 | — | — | WO | claimed |
| EP-0147222-A2 | Composition for use in preserving hydrocarbon products | STERWIN AG. (CH) | 1985-07-03 | — | — | EP | claimed |
| EP-0093604-A1 | Fungicidal carbamates and thiolcarbamates | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1983-11-09 | — | — | EP | claimed |
| JP-6298615-A | — | — | None | — | — | JP | disclosed |
| WO-2023218403-A1 | COMPOSITION COMPRISING A PHTHALIMIDE FUNGICIDE AND AN ACETIC ACID-BASED BUFFER | ADAMA MAKHTESHIM LTD. (IL) | 2023-11-16 | — | — | WO | disclosed |
| EP-4255187-A1 | DITHIOCARBAMATE FUNGICIDE COMPOSITION | ADAMA MAKHTESHIM LTD. (IL) | 2023-10-11 | — | — | EP | disclosed |
| US-11466246-B2 | Microbial conversion of CO2 and other C1 substrates to vegan nutrients, fertilizers, biostimulants, and systems for accelerated soil carbon sequestration | KIVERDI, INC. (US) | 2022-10-11 | — | — | US | disclosed |
| US-3935224-A | 4H-Pyrido[3,2a]-1,3,2-dioxophosphorane derivatives | CIBA-GEIGY CORPORATION (US) | 1976-01-27 | — | — | US | disclosed |
| US-3934010-A | MITICIDE | CIBA-GEIGY CORPORATION (US) | 1976-01-20 | — | — | US | disclosed |
| US-3932629-A | Triazolyl phosphorus esters as pesticides | CIBA-GEIGY CORPORATION (US) | 1976-01-13 | — | — | US | disclosed |
| US-3932509-A | FUNGICIDES, VIRICIDES | CIBA-GEIGY CORPORATION (US) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030149088-A1 | HIV treatment | BCOR, CYP3A4, NNT | ALDH1A1 1790/4885NPC1 23/4885RAB9A 4112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.